Price (delayed)
$1.79
Market cap
$142.19M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.07
Enterprise value
$247.34M
Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. The Accelerate Pheno® system and Accelerate PhenoTest® BC
There are no recent dividends present for AXDX.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.